Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000929638-24-003740
Filing Date
2024-11-05
Accepted
2024-11-05 13:46:14
Documents
1

Document Format Files

Seq Description Document Type Size
1 sc13g.htm SC 13G 59203
  Complete submission text file 0000929638-24-003740.txt   60983
Mailing Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022
Business Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022 (646) 293-2100
SEELOS THERAPEUTICS, INC. (Subject) CIK: 0001017491 (see all company filings)

EIN.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-53409 | Film No.: 241426819
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 4800 MONTGOMERY LANE SUITE 150 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 150 BETHESDA MD 20814 (877) 843-3831
AdvisorShares Trust (Filed by) CIK: 0001408970 (see all company filings)

EIN.: 260636087 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13G